Evolent Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Evolent Health generated cash of $142,582,000, which is more than the previous year. Cash used in financing activities reached the amount of $281,340,000 last year. Net change in cash is therefore $8,299,000.
Cash Flow
| 2014 | -75.09M | -3.57M | -1.36M |
|---|---|---|---|
| 2015 | -19.82M | -43.68M | 209.23M |
| 2016 | -35.51M | -97.79M | 122.14M |
| 2017 | -27.95M | -12.26M | 165.55M |
| 2018 | -20.65M | -160.37M | 274.02M |
| 2019 | -42.64M | -181.63M | -35.54M |
| 2020 | -16.22M | 261.07M | -11.86M |
| 2021 | 38.74M | -15.78M | -29.54M |
| 2022 | -11.55M | -259.11M | 131.54M |
| 2023 | 142.58M | -415.54M | 281.34M |
EVH Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 215.15M | 354.94M | 361.58M | 128.53M | 388.32M | 295.36M | 170.02M | 145.72M | 0 | 0 |
Operating activities | ||||||||||
Net income | -113.04M | -19.16M | -37.60M | -334.24M | -305.58M | -54.19M | -69.76M | -226.77M | 319.81M | -25.24M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 123.41M | 67.19M | 60.03M | 61.47M | 60.91M | 44.51M | 32.36M | 17.22M | 7.16M | 0 |
Stock-based compensation expense | 40.50M | 33.98M | 16.71M | 14.60M | 15.61M | 0 | 20.43M | 22.50M | 14.73M | 0 |
| Deferred income tax benefit | 40.50M | 33.98M | 16.71M | 14.60M | 15.61M | 0 | 20.43M | 22.50M | 14.73M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -164.69M | -102.98M | -5.77M | -47.01M | 6.32M | -24.50M | -11.25M | -11.04M | 11.75M | 0 |
Inventories | -10.74M | 0 | -14.11M | 47.01M | -19.50M | 644K | -1.83M | 5.10M | -5.76M | 0 |
Accounts payable | -6.72M | 13.16M | 7.25M | 3.54M | -5.48M | 7.59M | 5.56M | -6.37M | 2.76M | 0 |
Cash generated by operating activities | 142.58M | -11.55M | 38.74M | -16.22M | -42.64M | -20.65M | -27.95M | -35.51M | -19.82M | -75.09M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -5.55M | -2.99M | -11.17M | -11.12M | -10.01M | -3.80M | -9.09M | -54.23M | 0 |
Investments In Property Plant And Equipment | -28.74M | -38.36M | -24.98M | -29.47M | -35.53M | -39.55M | -27.84M | -15.52M | -6.51M | -11.03M |
Acquisitions Net | 0 | 5.55M | -34.79M | -300K | -96.05M | -139.60M | -4.82M | -85.56M | 13.06M | 0 |
Cash generated by investing activities | -415.54M | -259.11M | -15.78M | 261.07M | -181.63M | -160.37M | -12.26M | -97.79M | -43.68M | -3.57M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 4.45M | 13.28M | 2.57M | 1.09M | 11.92M | 166.94M | 177.79M | 209.08M | 0 |
Payments for dividends | -18.79M | -14.88M | -1.3M | -20M | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -18.31M | -3.85M | -1.85M | -2.60M | -1.23M | 0 | -365K | 0 | 0 |
Repayments of term debt | 183.29M | 160.29M | -98.84M | -16.60M | 62.64M | -167.17M | 0 | -121.25M | 0 | 0 |
Cash used in financing activities | 281.34M | 131.54M | -29.54M | -11.86M | -35.54M | 274.02M | 165.55M | 122.14M | 209.23M | -1.36M |
Net Change In Cash | 8.29M | -139.78M | -6.63M | 233.05M | -259.79M | 92.96M | 125.33M | -11.16M | 145.72M | -80.03M |
Cash at end of period | 223.45M | 215.15M | 354.94M | 361.58M | 128.53M | 388.32M | 295.36M | 134.56M | 145.72M | -80.03M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |